Recurrent Adenomatous Neuroendocrine Tumor of the Middle Ear: A Diagnostic Challenge.

Case Rep Otolaryngol

ENT Department, Clinique Saint-Pierre, 9 Av Reine Fabiola, 1340 Ottignies LLN, Belgium.

Published: November 2018

Middle ear adenomatous neuroendocrine tumor (MEANT) poses a diagnostic challenge. Clinical symptoms are nonspecific. Definite diagnosis is made by histopathological analysis of the tumor after a complete surgical resection based on an extensive computed tomography/magnetic resonance imaging (CT/MRI). Controversial terminology of the neoplasm arises from the differentiation of this tumor composed of both endocrine and exocrine glands. Middle ear (ME) localization is rare and less aggressive than gastrointestinal tract or lung localizations. Nevertheless, clinical and CT/MRI analyses are necessary follow-ups for preventing or detecting recurrence or metastasis. A case of a female patient aged 26 with recurrent middle ear neuroendocrine adenoma is presented herein.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286763PMC
http://dx.doi.org/10.1155/2018/8619434DOI Listing

Publication Analysis

Top Keywords

middle ear
16
adenomatous neuroendocrine
8
neuroendocrine tumor
8
diagnostic challenge
8
recurrent adenomatous
4
tumor
4
middle
4
tumor middle
4
ear
4
ear diagnostic
4

Similar Publications

A 73-year-old male with a history of incidentally diagnosed Paget disease of bone affecting the skull and left orbit 2 years prior presented with 3 months of vision loss, proptosis, and periorbital swelling of the OS. Examination showed best-corrected Snellen visual acuity of 20/150 in the affected eye, intact motility, 7 mm of relative proptosis, significant dilated and tortuous "corkscrew" conjunctival vessels, serous choroidal and retinal detachments, optic nerve hyperemia, and venous tortuosity and dilation. Although the bony lesions in the left orbit were stable from 1 year prior on imaging, the diagnostic angiogram demonstrated osseous blush and hypervascularity of the lesion.

View Article and Find Full Text PDF

How a gene fuels ear infections.

Elife

January 2025

Université Paris Cité, Institut Pasteur, AP-HP, Inserm, CNRS, Fondation Pour l'Audition, Institut de l'Audition, IHU reconnect, Progressive Sensory Disorders, Pathophysiology and Therapy Unit, Paris, France.

The DYRK1A enzyme is a pivotal contributor to frequent and severe episodes of otitis media in Down syndrome, positioning it as a promising target for therapeutic interventions.

View Article and Find Full Text PDF

Background: Uncontrolled severe eosinophilic chronic rhinosinusitis (eCRS) is associated with elevated levels of Th2 cells and raised immunoglobulin concentrations in nasal polyp tissue. eCRS is characterized by high eosinophilic infiltration and type 2 inflammation. Gαi1/3 proteins participate in allergic inflammation by regulating immune cells.

View Article and Find Full Text PDF

Acute necrotizing otitis media is a severe middle ear infection which causes necrosis of the tympanic cavity. A 54-year-old female was presented who suffered from diabetes mellitus and end-stage renal disease presenting with severe otalgia, initially thought to be necrotizing otitis externa. She rapidly progressed to total necrosis of the tympanic membrane.

View Article and Find Full Text PDF

BACKGROUND The Carhart effect consists of a reduction in bone conduction thresholds associated with conductive hearing loss. The aim of this study was to evaluate the role of the Carhart effect in predicting outcomes from surgery in 3 age groups. MATERIAL AND METHODS This study included 532 patients with conductive hearing loss due to otosclerosis, otitis media with effusion, and chronic otitis media who underwent surgery between 2010 and 2020.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!